Glenmark Life Sciences reports 33% fall in Q4 net profit

25 Apr 2024 Evaluate

Glenmark Life Sciences has reported results for fourth quarter (Q4) and year ended March 31, 2024.

The company has reported 33.08% fall in its net profit at Rs 97.94 crore for the quarter under review as compared to Rs 146.36 crore for the same quarter in the previous year. Total income of the company decreased by 13.53% at Rs 539.73 crore for Q4FY24 as compared Rs 624.16 crore for the corresponding quarter previous year. 

For the year ended March 31, 2024, the company has reported marginal rise of 0.84% in its net profit at Rs 470.89 crore as compared to Rs 466.96 crore for the previous year. Total income of the company increased by 4.80% at Rs 2295.26 crore for year under review as compared to Rs 2190.18 crore for year ended March 31, 2023.

Alivus Life Sciences Share Price

907.15 1.75 (0.19%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×